Ghent University Academic Bibliography

Your filters: cql: author="Jansen, Yanina" or (type any "bookEditor issueEditor" and editor="Jansen, Yanina")

Add to list
- Journal Article
- A1
- open access
Reducing the environmental impact of surgery on a global scale : systematic review and co-prioritization with healthcare workers in 132 countries

Adewale Adisa, Michael Bahrami-Hessari, Aneel Bhangu, Christina George, Dhruv Ghosh, James Glasbey, Parvez Haque, J C Allen Ingabire, Sivesh Kathir Kamarajah, Laura Kudrna, et al.

(2023) BRITISH JOURNAL OF SURGERY. 110(7). p.804-817
Add to list
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Yanina Jansen, Vibeke Kruse (UGent) , Jurgen Corthals, Kelly Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez (UGent) , Mark Kockx, Kris Thielemans, et al.

(2020) CANCER IMMUNOLOGY IMMUNOTHERAPY. 69(12). p.2589-2598
Add to list
- Conference Paper
- C3
Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab

Kelly Schats, Emily A Van Vre, Isolde Debyser, Arno Vandenbroeck, Yanina Jansen, Teofila Seremet, Koen Marien, Erik Fransen, Dorien Schrijvers, Wim Van Criekinge (UGent) , et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(suppl. 15).
Add to list
- Journal Article
- A1
- open access
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Teofila Seremet, Alexander Koch (UGent) , Yanina Jansen, Max Schreuer, Sofie Wilgenhof, Véronique Del Marmol, Danielle Liènard, Kris Thielemans, Kelly Schats, Mark Kockx, et al.

(2016) JOURNAL OF TRANSLATIONAL MEDICINE. 14.
Add to list
- Conference Paper
- C3
Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy

Teofila Seremet, Alexander Koch, Sofie Wilgenhof, Max Schreuer, Yanina Jansen, Danielle Lienard, Veronique Del Marmol, Kris Thielemans, Nicolas Van Baren, Pierre Coulie, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(15, suppl.).

Academic Bibliography

Reducing the environmental impact of surgery on a global scale : systematic review and co-prioritization with healthcare workers in 132 countries

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy

Contents

Support

Contact